| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9603ec17ce898c04dcb9a498f499a155 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate |
2008-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23fbfa95e79f5cd41cf8ee1823bdf762
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ff52a3f6ca6cfd85787272fc8776397 |
| publicationDate |
2009-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101407515-A |
| titleOfInvention |
Chinoline polycyclic compounds as CDK inhibitors |
| abstract |
The invention provides a quinoline polycyclic compound of general formula I which is used as a CDK inhibitor, and R1, R2, R3 and R4 in the formula are defined in the description. The invention also provides the synthetic route and the preparing method of the compound and the application in treating proliferating diseases of the compound and pharmaceutically acceptable salts of the compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021217508-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2561118-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107434808-A |
| priorityDate |
2008-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |